跳至主要内容
临床试验/ISRCTN93328851
ISRCTN93328851招募中未知

Double-blind randomized controlled trial comparing platelet-rich plasma, autologous blood and dry needling for chronic patellar tendinopathy

Arthrex Inc. (USA)0 个研究点目标入组 111 人开始时间: 2013年7月19日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
111

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. History (> 3 mo) of exercise-associated pain along the proximal insertion of the patellar tendon or pain or tenderness on palpation at this site or pain during provocative tests of the knee extensors
  • 2. And having one of the following ultrasound finding:
  • 2.1. Hypoechoic regions
  • 2.2. Intratendinous tears
  • 2.3. Neovascularisation
  • 3. Being at least 18 years old, either sex

排除标准

  • 1. Bleeding disorders (hemophilia)
  • 2. Taking anticoagulants (except aspirin)
  • 3. Severe anemia
  • 4. Cancer or metastases
  • 5. Pregnant or breastfeeding women
  • 6. Presence of infection at the time of evaluation
  • 7. History of knee surgery
  • 8. Inflammatory arthritis affecting the knee
  • 9. Corticosteroid injections within 30 days preceding the study

研究者

发起方
Arthrex Inc. (USA)

相似试验